9-21228049-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_021268.2(IFNA17):āc.125C>Gā(p.Ala42Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000259 in 1,614,030 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021268.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFNA17 | NM_021268.2 | c.125C>G | p.Ala42Gly | missense_variant | 1/1 | ENST00000413767.2 | NP_067091.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFNA17 | ENST00000413767.2 | c.125C>G | p.Ala42Gly | missense_variant | 1/1 | 6 | NM_021268.2 | ENSP00000411940.2 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152038Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000191 AC: 48AN: 251254Hom.: 0 AF XY: 0.000147 AC XY: 20AN XY: 135848
GnomAD4 exome AF: 0.000265 AC: 388AN: 1461874Hom.: 5 Cov.: 33 AF XY: 0.000243 AC XY: 177AN XY: 727242
GnomAD4 genome AF: 0.000197 AC: 30AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 09, 2024 | The c.125C>G (p.A42G) alteration is located in exon 1 (coding exon 1) of the IFNA17 gene. This alteration results from a C to G substitution at nucleotide position 125, causing the alanine (A) at amino acid position 42 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at